drugset / Trial / NCT00017446

CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00017446 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of CP4071 in treating patients who have locally advanced or metastatic soft tissue sarcoma.

Timeline

Start
2000-10
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CP4071 Unknown — Oral

Indications